Industries > Pharma > Global Stem Cell Technologies and Applications Market 2017-2027

Global Stem Cell Technologies and Applications Market 2017-2027

Cancer, Cardiovascular, CNS, Other Disease Areas and Non-Therapeutic Applications

PUBLISHED: 06 March 2017
PAGES: 261
PRODUCT CODE: PHA0173

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE

The global stem cell technologies and applications market is expected to grow at a CAGR of 13.4% in the first half of the forecast period and CAGR of 10.5% in the second half of the forecast period. The market is expected to grow at a CAGR of 11.7% from 2016 to 2027. The market is estimated at $10,751 million in 2016 and $17,768 million in 2020.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 257-page report you will receive 114 charts – all unavailable elsewhere.

The 257-page report provides clear detailed insight into the global stem cell technologies and applications market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Global Stem Cell Technologies and Applications Market 2017-2027

Report Scope
• Global Stem Cell Technologies and Applications Market forecasts
from 2017-2027

• Global Stem Cell Technologies and Applications submarket forecasts from 2017-2027:
– Cancer treatment
– Cardiovascular therapy
– CNS
– Other therapies
– Non-therapeutic applications

• Individual revenue forecast to 2027 for selected top products:
– MSC-100-IV (Mesoblast)
– Hearticellgram-AMI (Pharmicell)
– CardioRel (Reliance Life Sciences)
– Osteocel Plus (NuVasive)
– Trinity Evolution and Elite (Orthofix)
– CARTISTEM (MEDIPOST)

• Analysis of the most promising pipeline therapies in each therapeutic segment

• Discussion on regulatory environments and developments in the US, Japan, Europe and other leading countries

• Analysis of what drives and restrains the market

• This study also discusses other influences on that field, including these:
– Haematopoietic stem cell transplantation (HSCT)
– Embryonic stem cells (ESCs), induced pluripotent adult (IPSCs) and parthenogenetic cells
– Uses for umbilical cord blood and related technologies, including cellular and blood banking
– Agents for osteogenesis and treating autoimmune conditions
– Applications in cell-based assays, diagnostics and drug development.

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Stem Cell Technologies and Applications Market. You find data, trends and predictions.

Buy our report today Global Stem Cell Technologies and Applications Market 2017-2027: Cancer, Cardiovascular, CNS, Other Disease Areas and Non-Therapeutic Applications.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Stem Cell Technologies and Applications Market 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Stem Cell Technologies and Applications Market 2017-2027


Latest Pharma news

Visiongain Publishes Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market Report 2022-2032

The Macular Degeneration (AMD) and Other Retinal Diseases Drugs market was valued at US$25.29 billion in 2021 and is projected to grow at a CAGR of 7.87% during the forecast period 2022-2032.

25 November 2022

READ

Visiongain Publishes Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2022

Pharmaceutical Contract Manufacturing Organisations (CMOs) market is projected to grow at a CAGR of 6.9% by 2032.

25 November 2022

READ

Visiongain Publishes Dermatology CROs Market Report 2022-2032

The Dermatology CROs market was valued at US$ 5,154.8 million in 2021 and is projected to grow at a CAGR of 8.7% during the forecast period 2022-2032.

23 November 2022

READ

Visiongain Publishes Direct-to-Patient Market Report 2022-2032

The Direct-to-Patient market was valued at US$38,651 million in 2021 and is projected to grow at a CAGR of 6.1% during the forecast period 2022-2032.

22 November 2022

READ